ACADEMIC FRONTIERS
学术前沿
Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virus
上一篇：聚乙二醇化重组集成干扰素变异体治疗丙肝患者致精神不良反应的临床观察与心理干预
下一篇：Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selection
返回列表
